Deferoxamine-induced growth retardation in patients with thalassemia major
- 1 October 1988
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 113 (4), 661-669
- https://doi.org/10.1016/s0022-3476(88)80375-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia.Archives of Disease in Childhood, 1988
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- OCULAR TOXICITY OF HIGH-DOSE INTRAVENOUS DESFERRIOXAMINEThe Lancet, 1983
- Early iron overload in beta-thalassaemia major: when to start chelation therapy?Archives of Disease in Childhood, 1982
- Survival and desferrioxamine in thalassaemia major.BMJ, 1982
- Response to long-term deferoxamine therapy in thalassemiaThe Journal of Pediatrics, 1981
- Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamineThe Journal of Pediatrics, 1978
- Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.Archives of Disease in Childhood, 1976
- Clinical and Laboratory Studies on the Action of DesferrioxamineBritish Journal of Haematology, 1969
- The estimation of intestinal alkaline phosphatase in human blood serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1969